Frog sweat misuse – emerging evidence from India
Downloads
Published
Keywords:
Legal High, New Psychoactive substances, Frog sweat, misuse, opioid dependenceDimensions Badge
Issue
Section
License
Copyright (c) 2024 Gayatri Bhatia, Yoseph Kale

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Background: Cutaneous secretion of frogs (Kambo) have been reported to be misused for its opioid-like psycho-active effects, mostly from the Amazonian basin of Brazil and Peru. This is a unique case of frog sweat misuse in a middle-aged male with opioid dependence from India. Case description: A middle aged male presenting with symptoms of opioid withdrawal reported using frog sweat as an alternate, long-acting form of opioid in a dependent manner, for its much stronger psychoactive effect. Assessment and management using opioid substitution therapy along with motivational enhancement therpay have been discussed. Conclusion: Frog sweat (kambo) misuse is an emerging health risk in India along with different parts of the world and warrants reseach on epidemiology, clinical presentation, management guidelines along with its public health impact for effective regulation and control.Abstract
How to Cite
Downloads
Similar Articles
- Kumari Rina, Sujita Kumar Kar, Susanta Kumar Padhy, COVID-19 Chaos and New Psychoactive Substances: New Threats and Implications , Indian Journal of Clinical Psychiatry: Vol. 1 No. 1 (2021): Indian Journal of Clinical Psychiatry
- Kenil Jagani, Nidhi Doshi, Parag Shah, Psychosocial Factors Related to Attempted Suicide During COVID-19 Pandemic , Indian Journal of Clinical Psychiatry: Vol. 4 No. 01 (2024): Indian Journal of Clinical Psychiatry
- Pronob Kumar Dalal, Kopal Rohatgi, A Kaleidoscopic View of Substance Use in Uttar Pradesh , Indian Journal of Clinical Psychiatry: Vol. 1 No. 1 (2021): Indian Journal of Clinical Psychiatry
- Jasdeep Saluja, Successful Management of Polysubstance Dependence Syndrome with Endoxifen – A Case Report , Indian Journal of Clinical Psychiatry: Vol. 5 No. 01 (2025): Indian Journal of Clinical Psychiatry
- Ishwari Jadhav, Kunal Doshi, Case Report: Thalamic Stroke Patient with Neuropsychiatric Symptoms , Indian Journal of Clinical Psychiatry: Vol. 4 No. 01 (2024): Indian Journal of Clinical Psychiatry
- Shobit Garg, E. Mohandas, Cannabidiol (CBD) in Psychiatry: Therapeutic Potential and Challenges in the Indian Context , Indian Journal of Clinical Psychiatry: Vol. 5 No. 02 (2025): Indian Journal of Clinical Psychiatry
- Ankita Chattopadhyay, Gaurishanker Kaloiya, Siddharth Sarkar, Family Communication in the Context of Substance use: What do We Know and What Measures We can Take? , Indian Journal of Clinical Psychiatry: Vol. 2 No. 02 (2022): Indian Journal of Clinical Psychiatry
- Vangaveeti Sai Sobhana Sashank, Madhavi Kodali, Therissa Benerji, Attitude and Knowledge of High School Students Towards Substance Abuse , Indian Journal of Clinical Psychiatry: Vol. 5 No. 01 (2025): Indian Journal of Clinical Psychiatry
- Afzal Javed, Nazish Imran, Schools: A vital component of Child and Adolescent Mental Health , Indian Journal of Clinical Psychiatry: Vol. 3 No. 01 (2023): Indian Journal of Clinical Psychiatry
- Yashita Ahluwalia, Yatan Pal Singh Balhara, Ensuring Mental Well-being in the Digital World: Challenges and Approaches , Indian Journal of Clinical Psychiatry: Vol. 4 No. 01 (2024): Indian Journal of Clinical Psychiatry
You may also start an advanced similarity search for this article.



